Provention Bio, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

116,324

Value ($000)

2,803

Weight

0.0%

2020 Q2 - 2023 Q2 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	2,803	0.0%	116,324	6/30/2023
2023 Q1	5/15/2023	2,803	0.0%	116,324	3/31/2023
2022 Q4	2/14/2023	719	0.0%	68,045	12/31/2022
2022 Q3	11/14/2022	134	0.0%	29,716	9/30/2022
2022 Q2	8/12/2022	207	0.0%	51,851	6/30/2022
2022 Q1	5/16/2022	378	0.0%	51,670	3/31/2022
2021 Q4	2/14/2022	284	0.0%	50,622	12/31/2021
2021 Q3	11/15/2021	257	0.0%	40,211	9/30/2021
2021 Q2	8/16/2021	335	0.0%	39,700	6/30/2021
2021 Q1	5/14/2021	287	0.0%	27,300	3/31/2021
2020 Q4	3/1/2021	462	0.0%	27,300	12/31/2020
2020 Q3	11/13/2020	350	0.0%	27,300	9/30/2020
2020 Q2	8/14/2020	385	0.0%	27,300	6/30/2020